Charles River Laboratories International (CRL) News
NYSE: CRLHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
301.79+3.79 (+1.27%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CRL news summary
We found 4 recent headlines mentioning Charles River Laboratories International (CRL): 1 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, CRL is up 1.27% at $301.79. The most recent story, "Biotech Stocks At 52-Week Highs - PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%", was published by Nasdaq on Oct 6, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Charles River Laboratories International headlines
- Biotech Stocks At 52-Week Highs - PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%(RTTNews) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.NasdaqCRL, HTFL, ILMN, INFU
- Beat the Market the Zacks Way: FIGS, Microsoft, Amphenol in FocusFIGS, APH and MSFT post strong gains as Zacks upgrades and model portfolios spotlight stocks outperforming the broader market.NasdaqMSFT, ICE, ACN, PAYX
- Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.NasdaqCRL, HCA
- CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?Charles River's 33.3% monthly surge faces a higher bar as stronger bookings and guidance meet margin pressure and a premium valuation.NasdaqCRL, MEDP, IQV